Download PDF
J Neurol Surg B Skull Base 2018; 79(01): 058-064
DOI: 10.1055/s-0037-1617450
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Rhabdomyosarcoma of the Head and Neck: A Multimodal Approach

Dana L. Casey
1   Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States
,
Suzanne L. Wolden
1   Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States
› Author Affiliations
Further Information

Publication History

Publication Date:
18 January 2018 (online)

    Permissions and Reprints

Abstract

Head and neck rhabdomyosarcoma (HNRMS) is a uniquely challenging site to treat given the young patient age and critical anatomy of the head and neck region. We review the characteristics, management, and future directions in the treatment of HNRMS. Most patients who present with HNRMS have unresectable disease due to functional and/or cosmetic constraints. However, surgical resection and brachytherapy serve a critical role in select patients. The treatment paradigm for the majority of patients with HNRMS consists of definitive chemotherapy and radiation therapy. As the incidence of late toxicities increases with improved survival, modern efforts must focus on ways to decrease long-term morbidity. We recommend a multimodal approach emphasizing the preservation of form and function for the treatment of HNRMS.

Keywords

pediatric rhabdomyosarcoma - head and neck neoplasms - radiotherapy - brachytherapy
 

  • References

  • 1 Crist WM, Anderson JR, Meza JL. , et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 2001; 19 (12) 3091-3102
    CrossrefPubMedGoogle Scholar
  • 2 Pappo AS, Shapiro DN, Crist WM, Maurer HM. Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol 1995; 13 (08) 2123-2139
    CrossrefPubMedGoogle Scholar
  • 3 Maurer HM, Gehan EA, Beltangady M. , et al. The intergroup rhabdomyosarcoma study-II. Cancer 1993; 71 (05) 1904-1922
    CrossrefPubMedGoogle Scholar
  • 4 Ries LA, Smith MA, Gurney JG. , et al. Cancer incidence and survival among children and adolescents: United States SEER program. Publication no. 99-4649. Bethesda, MD: National Cancer Institute, SEER program, National Institutes of Health; 1999
    Google Scholar
  • 5 Raney Jr RB, Tefft M, Newton WA. , et al. Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites. A report from the intergroup rhabdomyosarcoma study. Cancer 1987; 59 (01) 147-155
    CrossrefPubMedGoogle Scholar
  • 6 Turc-Carel C, Lizard-Nacol S, Justrabo E, Favrot M, Philip T, Tabone E. Consistent chromosomal translocation in alveolar rhabdomyosarcoma. Cancer Genet Cytogenet 1986; 19 (3-4): 361-362
    CrossrefPubMedGoogle Scholar
  • 7 Barr FG, Smith LM, Lynch JC. , et al. Examination of gene fusion status in archival samples of alveolar rhabdomyosarcoma entered on the intergroup rhabdomyosarcoma study-III trial: a report from the Children's Oncology Group. J Mol Diagn 2006; 8 (02) 202-208
    CrossrefPubMedGoogle Scholar
  • 8 Skapek SX, Anderson J, Barr FG. , et al. PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report. Pediatr Blood Cancer 2013; 60 (09) 1411-1417
    CrossrefPubMedGoogle Scholar
  • 9 Michalski JM, Meza J, Breneman JC. , et al. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in intergroup rhabdomyosarcoma study group trials II through IV. Int J Radiat Oncol Biol Phys 2004; 59 (04) 1027-1038
    CrossrefPubMedGoogle Scholar
  • 10 Turner JH, Richmon JD. Head and neck rhabdomyosarcoma: a critical analysis of population-based incidence and survival data. Otolaryngol Head Neck Surg 2011; 145 (06) 967-973
    CrossrefPubMedGoogle Scholar
  • 11 Yang JC, Wexler LH, Meyers PA, Wolden SL. Parameningeal rhabdomyosarcoma: outcomes and opportunities. Int J Radiat Oncol Biol Phys 2013; 85 (01) e61-e66
    CrossrefPubMedGoogle Scholar
  • 12 Raney RB, Maurer HM, Anderson JR. , et al. The intergroup rhabdomyosarcoma study group (IRSG): major lessons from the IRS-I through IRS-IV studies as background for the current IRS-V treatment protocols. Sarcoma 2001; 5 (01) 9-15
    CrossrefPubMedGoogle Scholar
  • 13 Meazza C, Ferrari A, Casanova M. , et al. Rhabdomyosarcoma of the head and neck region: experience at the pediatric unit of the Istituto Nazionale Tumori, Milan. J Otolaryngol 2006; 35 (01) 53-59
    CrossrefPubMedGoogle Scholar
  • 14 Radzikowska J, Kukwa W, Kukwa A, Czarnecka A, Krzeski A. Rhabdomyosarcoma of the head and neck in children. Contemp Oncol (Pozn) 2015; 19 (02) 98-107
    PubMedGoogle Scholar
  • 15 Daya H, Chan HS, Sirkin W, Forte V. Pediatric rhabdomyosarcoma of the head and neck: is there a place for surgical management?. Arch Otolaryngol Head Neck Surg 2000; 126 (04) 468-472
    CrossrefPubMedGoogle Scholar
  • 16 Rodeberg DA, Wharam MD, Lyden ER. , et al. Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Int J Cancer 2015; 137 (01) 204-211
    CrossrefPubMedGoogle Scholar
  • 17 Paulino AC, Bauman N, Simon JH, Nguyen TX, Ritchie JM, Tannous R. Local control of parameningeal rhabdomyosarcoma: outcomes in non-complete responders to chemoradiation. Med Pediatr Oncol 2003; 41 (02) 118-122
    CrossrefPubMedGoogle Scholar
  • 18 Buwalda J, Blank LE, Schouwenburg PF. , et al. The AMORE protocol as salvage treatment for non-orbital head and neck rhabdomyosarcoma in children. Eur J Surg Oncol 2004; 30 (08) 884-892
    CrossrefPubMedGoogle Scholar
  • 19 Folkert MR, Tong WY, LaQuaglia MP. , et al. 20-year experience with intraoperative high-dose-rate brachytherapy for pediatric sarcoma: outcomes, toxicity, and practice recommendations. Int J Radiat Oncol Biol Phys 2014; 90 (02) 362-368
    CrossrefPubMedGoogle Scholar
  • 20 DeLaney TF, Chen GT, Mauceri TC. , et al. Intraoperative dural irradiation by customized 192iridium and 90yttrium brachytherapy plaques. Int J Radiat Oncol Biol Phys 2003; 57 (01) 239-245
    CrossrefPubMedGoogle Scholar
  • 21 King MT, Voros L, Cohen GN. , et al. High-dose-rate brachytherapy of rhabdomyosarcoma limited to the external auditory canal. Brachytherapy 2017; 16 (01) 181-185
    CrossrefPubMedGoogle Scholar
  • 22 Blank LE, Koedooder K, Pieters BR. , et al. The AMORE protocol for advanced-stage and recurrent nonorbital rhabdomyosarcoma in the head-and-neck region of children: a radiation oncology view. Int J Radiat Oncol Biol Phys 2009; 74 (05) 1555-1562
    CrossrefPubMedGoogle Scholar
  • 23 Buwalda J, Freling NJ, Blank LE. , et al. AMORE protocol in pediatric head and neck rhabdomyosarcoma: descriptive analysis of failure patterns. Head Neck 2005; 27 (05) 390-396
    CrossrefPubMedGoogle Scholar
  • 24 Wolden SL, Anderson JR, Crist WM. , et al. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: a report from the intergroup rhabdomyosarcoma studies I to III. J Clin Oncol 1999; 17 (11) 3468-3475
    CrossrefPubMedGoogle Scholar
  • 25 Breneman J, Meza J, Donaldson SS. , et al. Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 study. Int J Radiat Oncol Biol Phys 2012; 83 (02) 720-726
    CrossrefPubMedGoogle Scholar
  • 26 Donaldson SS, Meza J, Breneman JC. , et al; Children's Oncology Group Soft Tissue Sarcoma Committee (formely Intergroup Rhabdomyosarcoma Group) representing the Children's Oncology Group and the Quality Assurance Review Center. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG. Int J Radiat Oncol Biol Phys 2001; 51 (03) 718-728
    CrossrefPubMedGoogle Scholar
  • 27 Raney RB, Walterhouse DO, Meza JL. , et al. Results of the intergroup rhabdomyosarcoma study group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly diagnosed patients with low-risk embryonal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. J Clin Oncol 2011; 29 (10) 1312-1318
    CrossrefPubMedGoogle Scholar
  • 28 Wolden SL, Wexler LH, Kraus DH, Laquaglia MP, Lis E, Meyers PA. Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 2005; 61 (05) 1432-1438
    CrossrefPubMedGoogle Scholar
  • 29 Kozak KR, Adams J, Krejcarek SJ, Tarbell NJ, Yock TI. A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas. Int J Radiat Oncol Biol Phys 2009; 74 (01) 179-186
    CrossrefPubMedGoogle Scholar
  • 30 Donaldson SS, Anderson JR. Rhabdomyosarcoma: many similarities, a few philosophical differences. J Clin Oncol 2005; 23 (12) 2586-2587
    CrossrefPubMedGoogle Scholar
  • 31 Benk V, Rodary C, Donaldson SS. , et al. Parameningeal rhabdomyosarcoma: results of an international workshop. Int J Radiat Oncol Biol Phys 1996; 36 (03) 533-540
    CrossrefPubMedGoogle Scholar
  • 32 Merks JH, De Salvo GL, Bergeron C. , et al. Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups. Ann Oncol 2014; 25 (01) 231-236
    CrossrefPubMedGoogle Scholar
  • 33 Stevens MC, Rey A, Bouvet N. , et al. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol 2005; 23 (12) 2618-2628
    CrossrefPubMedGoogle Scholar
  • 34 Pappo AS, Meza JL, Donaldson SS. , et al. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV. J Clin Oncol 2003; 21 (04) 638-645
    CrossrefPubMedGoogle Scholar
  • 35 Kraus DH, Saenz NC, Gollamudi S. , et al. Pediatric rhabdomyosarcoma of the head and neck. Am J Surg 1997; 174 (05) 556-560
    CrossrefPubMedGoogle Scholar
  • 36 Raney RB, Asmar L, Vassilopoulou-Sellin R. , et al; IRS Group of the Children's Cancer Group and the Pediatric Oncology Group. Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: a descriptive report from the intergroup rhabdomyosarcoma studies (IRS)-II and - III. Med Pediatr Oncol 1999; 33 (04) 362-371
    CrossrefPubMedGoogle Scholar
  • 37 Paulino AC, Simon JH, Zhen W, Wen BC. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 2000; 48 (05) 1489-1495
    CrossrefPubMedGoogle Scholar
  • 38 Lockney NA, Friedman DN, Wexler LH, Sklar CA, Casey DL, Wolden SL. Late toxicities of intensity-modulated radiation therapy for head and neck rhabdomyosarcoma. Pediatr Blood Cancer 2016; 63 (09) 1608-1614
    CrossrefPubMedGoogle Scholar
  • 39 Schoot RA, Slater O, Ronckers CM. , et al. Adverse events of local treatment in long-term head and neck rhabdomyosarcoma survivors after external beam radiotherapy or AMORE treatment. Eur J Cancer 2015; 51 (11) 1424-1434
    CrossrefPubMedGoogle Scholar
  • 40 Ladra MM, Szymonifka JD, Mahajan A. , et al. Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma. J Clin Oncol 2014; 32 (33) 3762-3770
    CrossrefPubMedGoogle Scholar
  • 41 Casey DL, Wexler LH, Fox JJ. , et al. Predicting outcome in patients with rhabdomyosarcoma: role of [(18)f]fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys 2014; 90 (05) 1136-1142
    CrossrefPubMedGoogle Scholar